Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II
Open Access
- 27 December 2020
- journal article
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 17 (4), 676-682
- https://doi.org/10.18008/1816-5095-2020-4-676-682
Abstract
Topical and systemic carbonic anhydrase inhibitors (CAIs) are widely used in the treatment of glaucoma for reducing intraocular pressure. This part of the review describes the characteristics of systemic CAIs, their side effects and the ways to overcome them, as well as contraindications. The use of CAIs during pregnancy is considered. Particular attention is paid to the antioxidant activity of CAIs and the promising development of hybrid forms based on the existing CAIs as a part of a multipurpose glaucoma treatment strategy.Keywords
This publication has 40 references indexed in Scilit:
- Topical dorzolamide for macular edema in the early phase after vitrectomy and epiretinal membrane removalClinical Ophthalmology, 2013
- A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucomaBioorganic & Medicinal Chemistry Letters, 2013
- Patient perspectives when switching from Cosopt® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapyClinical Ophthalmology, 2012
- Dithiocarbamates Strongly Inhibit Carbonic Anhydrases and Show Antiglaucoma Action in VivoJournal of Medicinal Chemistry, 2012
- A new approach to antiglaucoma drugs: carbonic anhydrase inhibitors with or without NO donating moieties. Mechanism of action and preliminary pharmacologyJournal of Enzyme Inhibition and Medicinal Chemistry, 2011
- Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practiceClinical Ophthalmology, 2011
- Compliance and adherence in glaucoma managementIndian Journal of Ophthalmology, 2011
- The Safety and Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 2%/Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular HypertensionJournal of Glaucoma, 2009
- Determinants of Adherence to Glaucoma Medical Therapy in a Long-term Patient PopulationJournal of Glaucoma, 2009
- Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sicknessJournal of Applied Physiology, 2007